SHAREHOLDER ALERT: Morris Kandinov Investigating PRVB, MAXR, DNA, and FOX; Shareholders are Encouraged to Contact the Firm
March 29, 2023 09:00 ET
|
Morris Kandinov, LLP
SAN DIEGO, March 29, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Provention Bio, Inc., Maxar Technologies Inc., Ginkgo Bioworks Holdings, Inc., and Fox Corporation....
Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 27, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors C3.ai, Inc. (NYSE:...
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 01, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ginkgo Bioworks Holdings,...
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
February 28, 2023 08:28 ET
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...
SHAREHOLDER ALERT: Morris Kandinov Investigating DNA, APA, LDI and BFLY; Shareholders are Encouraged to Contact the Firm
February 01, 2023 15:11 ET
|
Morris Kandinov, LLP
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating Ginkgo Bioworks Holdings, Inc., APA Corporation, loanDepot, Inc., and Butterfly Network, Inc. If you...
Dyadic Announces Sale of Equity Interest in Alphazyme
January 19, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Rayont Inc- RAYT- Reports 10-Q for the Three -Month Ending September 30, 2022, Financial Results.
January 17, 2023 09:00 ET
|
Rayont Inc
Palo Alto, California, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international personalized natural healthcare company, today reported financial...
BC Platforms Selected as Partner to Deliver key Singapore Population Health Study
January 09, 2023 02:00 ET
|
BC Platforms
ZURICH, Switzerland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has been selected as the platform of choice...
IMUNON Enters into Collaborative Research Agreement with The Wistar Institute’s Vaccine & Immunotherapy Center to Research IMUNON’s PLACCINE Vaccine Platform
January 05, 2023 08:30 ET
|
Imunon, Inc.
LAWRENCEVILLE, NJ and PHILADELPHIA, PA, Jan. 05, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, and The Wistar Institute, a global leader in...
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...